Evidence map›Paper›PMID 31050703›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Impact of Intravenous Fluid Therapy on Survival Among Patients With Ebola Virus Disease: An International Multisite Retrospective Cohort Study.

Adam R Aluisio, Derrick Yam, Jillian L Peters, Daniel K Cho, Shiromi M Perera, Stephen B Kennedy, Moses Massaquoi, Foday Sahr, Michael A Smit, Tao Liu and 1 more

Open access · greenAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Adam R AluisioDepartment of Emergency Medicine, Brown University Alpert Medical School, Rhode Island.
Derrick YamCenter for Statistical Sciences, Department of Biostatistics, Brown University School of Public Health, Rhode Island.
Jillian L PetersBrown University, Providence, Rhode Island.
Daniel K ChoBrown University, Providence, Rhode Island.
Shiromi M PereraInternational Medical Corps, Washington, District of Columbia, Liberia.
Stephen B KennedyMinistry of Health, Monrovia, Liberia.
Moses MassaquoiMinistry of Health, Monrovia, Liberia.
Foday SahrMinistry of Defense, Freetown, Sierra Leone.
Michael A SmitDivision of Infectious Diseases, Children's Hospital Los Angeles, California.
Tao LiuCenter for Statistical Sciences, Department of Biostatistics, Brown University School of Public Health, Rhode Island.
Adam C LevineDepartment of Emergency Medicine, Brown University Alpert Medical School, Rhode Island.
Brown University · USChildren's Hospital of Los Angeles · USInternational Medical Corps · USMinistry of Defence · SL

Funding

Tracking and Evaluation CoreU54GM115677 · NIGMS · BROWN UNIVERSITY · PI ROUNDS, SHARON IRENE SMITH · 2016 to 2025
$45.0M
Evaluation of Management Strategies for Maximizing Supportive Care for Patients with Ebola Virus DiseaseR03AI132801 · NIAID · RHODE ISLAND HOSPITAL · PI LEVINE, ADAM CARL · 2017 to 2018
$179k
NIAID NIH HHS R03 AI132801NIGMS NIH HHS U54 GM115677
6 · The paper itself

Abstract

backgroundIntravenous fluid (IVF) is a frequently recommended intervention in Ebola virus disease (EVD), yet its impact on patient outcomes remains unclear.

methodsThis retrospective cohort study evaluated patients with EVD admitted to 5 Ebola treatment units (ETUs) in West Africa. The primary outcome was the difference in 28-day survival between cases treated and not treated with IVF. To control for demographic and clinical factors related to both IVF exposure and survival, cases were compared using propensity score matching. To control for time-varying patient and treatment factors over the course of ETU care, a marginal structural proportional hazards model (MSPHM) with inverse probability weighting was used to assess for 28-day survival differences.

resultsAmong 424 EVD-positive cases with data for analysis, 354 (83.5%) were treated with IVF at some point during their ETU admission. Overall, 146 (41.3%) cases treated with IVF survived, whereas 31 (44.9%) cases not treated with any IVF survived (P = .583). Matched propensity score analysis found no significant difference in 28-day survival between cases treated and not treated with IVF during their first 24 and 48 hours of care. Adjusted MSPHM survival analyses also found no significant difference in 28-day survival for cases treated with IVF (27.3%) compared to those not treated with IVF (26.9%) during their entire ETU admission (P = .893).

conclusionsAfter adjustment for patient- and treatment-specific time-varying factors, there was no significant difference in survival among patients with EVD treated with IVF as compared to those not treated with IVF.

Indexed as

EbolavirusHemorrhagic Fever, EbolaAfrica, WesternFluid TherapyHumansRetrospective StudiesEbola virus diseaseintravenous fluidmarginal structural modelssurvivalWest Africa

Identifiers

PMID31050703
PMCPMC7390355
OpenAlexW2943016086

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.